Thymosin Beta-4 Fragment (LKKTETQ)

Recoverysubcutaneous

Short active fragment of thymosin β-4 (7 amino acids). Under PCAC review 2026.

Category
Recovery
Half-life
1.66667 days
Typical dose
1 mg to 2 mg
Route
Subcutaneous
Frequency
weekly
Cycle (on/off)
28 on / 14 off

What it is

Short active fragment of thymosin β-4 (7 amino acids). Under PCAC review 2026.

Common uses

Users track this peptide for soft-tissue repair, tendon and ligament discomfort, and gut-related recovery.

Reconstitution guidance

Typical vial size 5 mg. Reconstitute with 2 mL bacteriostatic water. Refrigerate after reconstitution per manufacturer or clinician guidance. Standard storage window: 28d refrigerated.

Stack combinations

Commonly tracked alongside other recovery peptides in the same stack. Stack partners vary by protocol and clinician guidance.

Cycle length norms

Tracked users commonly run 28 on / 14 off. Cycle norms vary by individual and by clinician guidance. Pepture lets you configure any on/off window that matches your protocol.

Safety considerations

Every peptide carries context-specific risks. Work with a licensed clinician who knows your medical history before starting or adjusting a protocol. Stop and seek medical attention for severe injection site reactions, unexpected swelling, shortness of breath, persistent elevated heart rate, rash, or any reaction you did not anticipate. Pepture does not assess efficacy or safety for any individual.

References

For peer-reviewed literature, search PubMed for Thymosin Beta-4 Fragment (LKKTETQ). Pepture does not link to vendor or retail sites.

Disclaimer

The information on this page is for informational purposes only and is not medical, legal, or regulatory advice. Pepture does not sell, supply, prescribe, or recommend any peptide. Many peptides are investigational or restricted in specific jurisdictions.

← Back to peptide library